(Reuters) March 5 – Private equity firms including Blackstone Group LP and Carlyle Group are exploring a joint offer for Life Technologies Corp, a biomedical laboratory equipment maker with a $10 billion market value, two people familiar with the matter said on Tuesday.
The buyout consortium – which also comprises private equity firm TPG Capital and Singapore’s state investor Temasek Holdings – is at a preliminary stage of discussions, and it remains unclear if the group will proceed with a bid, the two sources said.
The group thinks Life Tech’s stock price has reached a level where it would be tough to make the economics of a deal attractive, the sources added, asking not to be named because the matter is not public.